» Articles » PMID: 23182839

Gender Differences in Cannabis Use Disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2012 Nov 28
PMID 23182839
Citations 144
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To examine gender differences among individuals diagnosed with DSM-IV lifetime cannabis use disorder (CUD).

Methods: A nationally representative sample of U.S. adults aged 18 years or older that were diagnosed with lifetime CUD (n=3297): Men (n=2080), Women (n=1217). Data were drawn from the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC, n=43,093). The survey response rate was 81%.

Results: Nearly all individuals with CUD had a psychiatric comorbidity (95.6% of men, 94.1% of women). Men with lifetime CUD were more likely than women to be diagnosed with any psychiatric disorder, any substance use disorder and antisocial personality disorder, whereas women with CUD had more mood and anxiety disorders. After adjusting for gender differences in sociodemographic correlates and the prevalence of psychiatric disorders in the general population, women with CUD were at greater risk for externalizing disorders. Men with CUD met more criteria for cannabis abuse, had longer episodes of CUD, smoked more joints, and were older at remission when compared to women with CUD. Women experienced telescoping to CUD. Treatment-seeking rates were very low for both genders, and there were no gender differences in types of services used or reasons for not seeking treatment.

Conclusions: There are important gender differences in the clinical characteristics and psychiatric comorbidities among individuals with CUD.

Citing Articles

Cannabis use across the menstrual cycle: The impact of negative affect and cannabis use motives.

Morris P, Soto P, Buckner J Addict Behav. 2025; 164:108284.

PMID: 39923384 PMC: 11854502. DOI: 10.1016/j.addbeh.2025.108284.


Sex differences in normative modeling of cortical thickness in cannabis use disorder.

Martin E, Campbell L, Thorn K, Sahlem G, McRae-Clark A, Benitez A Drug Alcohol Depend Rep. 2025; 14:100318.

PMID: 39897590 PMC: 11783377. DOI: 10.1016/j.dadr.2025.100318.


Gender-related differences in addiction: a review of human studies.

Zakiniaeiz Y, Potenza M Curr Opin Behav Sci. 2025; 23:171-175.

PMID: 39896826 PMC: 11784943. DOI: 10.1016/j.cobeha.2018.08.004.


Psychosis associated with cannabis withdrawal: systematic review and case series.

Chesney E, Reilly T, Scott F, Slimani I, Sarma A, Kornblum D Br J Psychiatry. 2024; :1-12.

PMID: 39624030 PMC: 7617269. DOI: 10.1192/bjp.2024.175.


Sexism and Cannabis-Related Problems Among Women in the U.S.: The Role of Negative Affect and Coping-Motivated Cannabis Use.

Morris P, Thomas K, Buckner J Subst Use Misuse. 2024; 60(2):168-175.

PMID: 39491321 PMC: 11710988. DOI: 10.1080/10826084.2024.2422944.


References
1.
Kessler R, Aguilar-Gaxiola S, Berglund P, Dewit D, GREENFIELD S, Kolody B . Patterns and predictors of treatment seeking after onset of a substance use disorder. Arch Gen Psychiatry. 2001; 58(11):1065-71. DOI: 10.1001/archpsyc.58.11.1065. View

2.
Tavares H, Martins S, Lobo D, Silveira C, Gentil V, Hodgins D . Factors at play in faster progression for female pathological gamblers: an exploratory analysis. J Clin Psychiatry. 2003; 64(4):433-8. DOI: 10.4088/jcp.v64n0413. View

3.
Grant B, Hasin D, Blanco C, Stinson F, Chou S, Goldstein R . The epidemiology of social anxiety disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006; 66(11):1351-61. DOI: 10.4088/jcp.v66n1102. View

4.
Wagner F, Anthony J . From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology. 2002; 26(4):479-88. DOI: 10.1016/S0893-133X(01)00367-0. View

5.
Agresti A, Min Y . Unconditional small-sample confidence intervals for the odds ratio. Biostatistics. 2003; 3(3):379-86. DOI: 10.1093/biostatistics/3.3.379. View